A&O-Led Ipsen To Buy Blood Cancer Research Biz For €1B
Global biopharmaceutical company Ipsen said Wednesday that it will acquire a biotechnology company, ImCheck Therapeutics, from a consortium of French, European and U.S. investors for up to €1 billion ($1.16 billion)...To view the full article, register now.
Already a subscriber? Click here to view full article